Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03022409
Title A Study to Investigate Biomarker Effects of Pre-Surgical Treatment With DNA Damage Repair (DDR) Agents in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC)
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors AstraZeneca
Indications

head and neck squamous cell carcinoma

Therapies

Olaparib

Ceralasertib

Age Groups: adult | senior
Covered Countries USA | FRA

Facility Status City State Zip Country Details
Research Site Pittsburgh Pennsylvania 15240 United States Details
Research Site Toulouse 31300 France Details
Research Site Changhua City 50006 Taiwan Details
Research Site Taipei 100 Taiwan Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field